Abbie Cornett, chair and president of The Alliance for Biotherapeutics, advocates for patients who lack access to lifesaving therapies, have reimbursement restrictions and/or are denied coverage.
In the world of immune globulin, the demonstrated potential of these miraculous proteins to save and sustain lives is often thwarted by the complex and intertwined encumbrances that continually create barriers to access.
After being misdiagnosed with indigestion, Carolyn Thomas lived to tell what it’s like to be a heart attack survivor. Her mission? To help other women foil this all-too-common killer.
In this issue of BioSupply Trends Quarterly, we honor the past as we look to an exciting future where once-prominent diseases will continue to be minimized or even eradicated.
A rare neuromuscular disease left once-active senior Thelma Christison too weak to get out of bed. But intravenous immune globulin has helped her to significantly recover
BSTQ talks vaccine news and updates, and explores new uses for this life-saving technology.
Once considered a “super drug,” antibiotics are becoming increasingly ineffective against a host of new “super bugs.” Retiree Betty Gordon provides a glimpse into what it’s like to live with a growing list of relentless infections.
With more than two decades of leadership in the vaccine industry, Damian A. Braga talks leadership, passion for public health and vision for the future.
If you think Alzheimer’s disease affects only the very elderly, think again. Early-onset Alzheimer’s can strike in midlife, with devastating consequences. But hope is on the horizon.
This issue of BSTQ explores blood and blood products: the risks, the benefits and everything in between, as well as skin cancer, healthcare reform and more.
With a relational style and personal integrity, Chris Ground has helped FFF Enterprises cultivate a flawless safety track record.
In an industry affected by a multitude of interconnected, difficult-tocontrol variables, two things consistently stand out among manufacturers and distributors of plasma derivatives: a dedication to better patient outcomes and a passion for continuous improvement.